chronic myeloproliferative disorder


Also found in: Acronyms.

chronic myeloproliferative disorder

A generic term for the autonomous proliferation of myelopoietic stem cells.

Chronic myeloproliferative disorders
• Common—Chronic myeloid leukaemia, polycythemia vera, essential thrombocythemia, chronic idiopathic myelofibrosis.
• Uncommon—Chronic neutrophilic leukaemia, chronic eosinophilic leukaemia/hypereosinophilic syndrome, chronic myeloproliferative disease, unclassifiable.
References in periodicals archive ?
JAK2 V617F mutation was detected in 68 per cent (51 of 75) patients with chronic myeloproliferative disorders.
The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome negative chronic myeloproliferative disorders.
Soluble angiogenic factors: implications for chronic myeloproliferative disorders.
For over 50 years, HU has been used in the treatment of chronic myeloproliferative disorders, such as chronic myeloid leukemia, polycythemia vera, and ET (3).
Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders.
Chronic myeloproliferative disorders (MPDs) include polycythemia vera, chronic myelocytic leukemia, essential thrombocythemia, and myelofibrosis with myeloid metaplasia.
Genzyme has also made available a new assay that detects a mutation in the Janus kinase 2 (JAK2) gene common in chronic myeloproliferative disorders (MPDs).
Granulocytic sarcoma (GS) is the tumoral infiltration of extramedullary sites with immature myeloid precursor cells; it is associated with 3%-8% of acute myeloid leukemia (AML) cases and rarely with chronic myeloproliferative disorders 11].
Chronic myeloproliferative disorders (CMPDs) are a group of heterogeneous clonal stem cell disorders that can be defined by specific cytomorphological phenotypes and sometimes genetic features (1).

Full browser ?